Epigenetics, chromatin and genome organization: Recent advances from the ENCODE project

Journal of Internal Medicine

Volumn 276, Issue 3, 2014, Pages 201-214

  Siggens, L ^a   Ekwall, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chromatin; DNA methylation; Epigenetics; Histone; Transcription

Indexed keywords

CHROMATIN; DNA METHYLATION; EPIGENETICS; HISTONE; TRANSCRIPTION;

CHROMATIN; CHROMOSOME MAPPING; DNA METHYLATION; EPIGENESIS, GENETIC; FORECASTING; GENOME, HUMAN; HISTONES; HUMAN GENOME PROJECT; HUMANS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84905718857     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12231     Document Type: Review

References (96)

1. Dawson MA, Kouzarides T, Huntly BJ. Targeting epigenetic readers in cancer. N Engl J Med 2012; 367: 647-57.
2. Rivera CM, Ren B. Mapping human epigenomes. Cell 2013; 155: 39-55.
3. Vialou V, Feng J, Robison AJ, Nestler EJ. Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol 2013; 53: 59-87.
4. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17: 330-9.
5. Sharma SV, Lee DY, Li B et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010; 141: 69-80.
6. Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 2012; 11: 384-400.
7. Wang Z, Zang C, Rosenfeld JA et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40: 897-903.
8. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484-92.
9. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
10. Lister R, Pelizzola M, Dowen RH et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462: 315-22.
11. Kass SU, Landsberger N, Wolffe AP. DNA methylation directs a time-dependent repression of transcription initiation. Curr Biol 1997; 7: 157-65.
12. Boyes J, Bird A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 1991; 64: 1123-34.
13. Jones PL, Veenstra GJ, Wade PA et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19: 187-91.
14. Watt F, Molloy PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev 1988; 2: 1136-43.
15. Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S. Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 2008; 456: 125-9.
16. Maunakea AK, Nagarajan RP, Bilenky M et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010; 466: 253-7.
17. Maunakea AK, Chepelev I, Cui K, Zhao K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res 2013; 23: 1256-69.
18. Shukla S, Kavak E, Gregory M et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011; 479: 74-9.
19. Burgess RJ, Zhang Z. Histone chaperones in nucleosome assembly and human disease. Nat Struct Mol Biol 2013; 20: 14-22.
20. Narlikar GJ, Sundaramoorthy R, Owen-Hughes T. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell 2013; 154: 490-503.
21. Ahmad K, Henikoff S. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 2002; 9: 1191-200.
22. Ku M, Jaffe JD, Koche RP et al. H2A.Z landscapes and dual modifications in pluripotent and multipotent stem cells underlie complex genome regulatory functions. Genome Biol 2012; 13: R85.
23. Hu G, Cui K, Northrup D et al. H2A.Z facilitates access of active and repressive complexes to chromatin in embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2013; 12: 180-92.
24. Fu Y, Sinha M, Peterson CL, Weng Z. The insulator binding protein CTCF positions 20 nucleosomes around its binding sites across the human genome. PLoS Genet 2008; 4: e1000138.
25. Jin C, Zang C, Wei G et al. H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nat Genet 2009; 41: 941-5.
26. Nekrasov M, Amrichova J, Parker BJ et al. Histone H2A.Z inheritance during the cell cycle and its impact on promoter organization and dynamics. Nat Struct Mol Biol 2012; 19: 1076-83.
27. Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA. Gene reactivation by 5-aza-2′-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. PLoS Genet 2012; 8: e1002604.
28. Suganuma T, Workman JL. Signals and combinatorial functions of histone modifications. Annu Rev Biochem 2011; 80: 473-99.
29. Zentner GE, Henikoff S. Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 2013; 20: 259-66.
30. Bartke T, Vermeulen M, Xhemalce B, Robson SC, Mann M, Kouzarides T. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 2010; 143: 470-84.
31. Heintzman ND, Hon GC, Hawkins RD et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459: 108-12.
32. Lauberth SM, Nakayama T, Wu X et al. H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation. Cell 2013; 152: 1021-36.
33. Sims RJ, Millhouse S, Chen CF et al. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol Cell 2007; 28: 665-76.
34. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002; 16: 919-32.
35. Matsui T, Leung D, Miyashita H et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 2010; 464: 927-31.
36. Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 2012; 48: 491-507.
37. Liu H, Chen Y, Lv J et al. Quantitative epigenetic co-variation in CpG islands and co-regulation of developmental genes. Sci Rep 2013; 3: 2576.
38. Voigt P, Tee WW, Reinberg D. A double take on bivalent promoters. Genes Dev 2013; 27: 1318-38.
39. Heintzman ND, Stuart RK, Hon G et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39: 311-18.
40. Hong L, Schroth GP, Matthews HR, Yau P, Bradbury EM. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol Chem 1993; 268: 305-14.
41. Tropberger P, Pott S, Keller C et al. Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer. Cell 2013; 152: 859-72.
42. Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 2007; 76: 75-100.
43. Kundu TK, Palhan VB, Wang Z, An W, Cole PA, Roeder RG. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol Cell 2000; 6: 551-61.
44. Weinberger L, Voichek Y, Tirosh I, Hornung G, Amit I, Barkai N. Expression noise and acetylation profiles distinguish HDAC functions. Mol Cell 2012; 47: 193-202.
45. Wirén M, Silverstein RA, Sinha I et al. Genomewide analysis of nucleosome density histone acetylation and HDAC function in fission yeast. EMBO J 2005; 24: 2906-18.
46. Perissi V, Jepsen K, Glass CK, Rosenfeld MG. Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet 2010; 11: 109-23.
47. Lennartsson A, Ekwall K. Histone modification patterns and epigenetic codes. Biochim Biophys Acta 2009; 1790: 863-8.
48. Consortium EP. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004; 306: 636-40.
49. Ernst J, Kheradpour P, Mikkelsen TS et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473: 43-9.
50. Bernstein BE, Birney E, Dunham I et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
51. Harrow J, Frankish A, Gonzalez JM et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012; 22: 1760-74.
52. Djebali S, Davis CA, Merkel A et al. Landscape of transcription in human cells. Nature 2012; 489: 101-8.
53. Johnsson P, Ackley A, Vidarsdottir L et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 2013; 20: 440-6.
54. Kalyana-Sundaram S, Kumar-Sinha C, Shankar S et al. Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 2012; 149: 1622-34.
55. Pei B, Sisu C, Frankish A et al. The GENCODE pseudogene resource. Genome Biol 2012; 13: R51.
56. Carninci P, Kasukawa T, Katayama S et al. The transcriptional landscape of the mammalian genome. Science 2005; 309: 1559-63.
57. Kodzius R, Kojima M, Nishiyori H et al. CAGE: cap analysis of gene expression. Nat Methods 2006; 3: 211-22.
58. Consortium EP. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011; 9: e1001046.
59. Carninci P, Sandelin A, Lenhard B et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 2006; 38: 626-35.
60. Prasad P, Rönnerblad M, Arner E et al. High-throughput transcription profiling identifies putative epigenetic regulators of hematopoiesis. Blood 2014; doi:10.1182/blood-2013-02-483537.
61. Rönnerblad M, Andersson R, Olofson T et al. Analysis of the DNA methylome and transcriptome in granulopoiesis reveal timed changes and dynamic enhancer methylation. Blood 2014; doi:10.1182/blood-2013-02-482893.
62. Song L, Crawford GE. DNase-seq: a high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harb Protoc 2010; 2010: pdb.prot5384.
63. Gribnau J, Diderich K, Pruzina S, Calzolari R, Fraser P. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol Cell 2000; 5: 377-86.
64. Hebbes TR, Clayton AL, Thorne AW, Crane-Robinson C. Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. EMBO J 1994; 13: 1823-30.
65. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res 2007; 17: 877-85.
66. Thurman RE, Rynes E, Humbert R et al. The accessible chromatin landscape of the human genome. Nature 2012; 489: 75-82.
67. Feldmann A, Ivanek R, Murr R, Gaidatzis D, Burger L, Schübeler D. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet 2013; 9: e1003994.
68. Stadler MB, Murr R, Burger L et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 2011; 480: 490-5.
69. Wang J, Zhuang J, Iyer S et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res 2012; 22: 1798-812.
70. He HH, Meyer CA, Shin H et al. Nucleosome dynamics define transcriptional enhancers. Nat Genet 2010; 42: 343-7.
71. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 2011; 43: 27-33.
72. Voss TC, Schiltz RL, Sung MH et al. Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell 2011; 146: 544-54.
73. Phillips JE, Corces VG. CTCF: master weaver of the genome. Cell 2009; 137: 1194-211.
74. Li G, Fullwood MJ, Xu H et al. ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing. Genome Biol 2010; 11: R22.
75. Handoko L, Xu H, Li G et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat Genet 2011; 43: 630-8.
76. Kim TH, Abdullaev ZK, Smith AD et al. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 2007; 128: 1231-45.
77. Wang H, Maurano MT, Qu H et al. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res 2012; 22: 1680-8.
78. Maston GA, Landt SG, Snyder M, Green MR. Characterization of enhancer function from genome-wide analyses. Annu Rev Genomics Hum Genet 2012; 13: 29-57.
79. Sanyal A, Lajoie BR, Jain G, Dekker J. The long-range interaction landscape of gene promoters. Nature 2012; 489: 109-13.
80. Birney E, Stamatoyannopoulos JA, Dutta A et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447: 799-816.
81. Li G, Ruan X, Auerbach RK et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012; 148: 84-98.
82. Jin F, Li Y, Dixon JR et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 2013; 503: 290-4.
83. Ward LD, Kellis M. Evidence of abundant purifying selection in humans for recently acquired regulatory functions. Science 2012; 337: 1675-8.
84. Hoffman MM, Ernst J, Wilder SP et al. Integrative annotation of chromatin elements from ENCODE data. Nucleic Acids Res 2013; 41: 827-41.
85. Green P, Ewing B. Comment on "Evidence of abundant purifying selection in humans for recently acquired regulatory functions". Science 2013; 340: 682.
86. Ward LD, Kellis M. Response to comment on "Evidence of abundant purifying selection in humans for recently acquired regulatory functions". Science 2013; 340: 682.
87. Graur D, Zheng Y, Price N, Azevedo RB, Zufall RA, Elhaik E. On the immortality of television sets: "function" in the human genome according to the evolution-free gospel of ENCODE. Genome Biol Evol 2013; 5: 578-90.
88. Maurano MT, Humbert R, Rynes E et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012; 337: 1190-5.
89. Landt SG, Marinov GK, Kundaje A et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 2012; 22: 1813-31.
90. Bernstein BE, Stamatoyannopoulos JA, Costello JF et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol 2010; 28: 1045-8.
91. Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why? Mol Cell 2013; 49: 825-37.
92. Deneberg S, Guardiola P, Lennartsson A et al. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood 2011; 118: 5573-82.
93. Haider S, Cordeddu L, Robinson E et al. The landscape of DNA repeat elements in human heart failure. Genome Biol 2012; 13: R90.
94. Movassagh M, Choy MK, Knowles DA et al. Distinct epigenomic features in end-stage failing human hearts. Circulation 2011; 124: 2411-22.
95. Tuupanen S, Turunen M, Lehtonen R et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009; 41: 885-90.
96. Cheng C, Alexander R, Min R et al. Understanding transcriptional regulation by integrative analysis of transcription factor binding data. Genome Res 2012; 22: 1658-67.